Sabine Vogler, Verena Knoll, Maximilian Salcher-Konrad
{"title":"Community pharmacy services in the late COVID-19 period: What has driven change?","authors":"Sabine Vogler, Verena Knoll, Maximilian Salcher-Konrad","doi":"10.1016/j.sapharm.2025.03.001","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Community pharmacy appears to have undergone considerable change over the years.</p><p><strong>Objectives: </strong>The objective of this research is to study the range of community pharmacy services provided in late stages of the COVID-19 pandemic and during the last decades and to identify potential drivers for change.</p><p><strong>Methods: </strong>Four European countries (Austria, England, Estonia, and Portugal), which represent a balance in terms of income, organization of the health system and pharmacy services, were selected as case studies. For each country, a factsheet on pharmacy services provided in 2023 and recent developments was populated based on a literature review and validated by country experts in community pharmacies. A semi-structured interview was conducted with a community pharmacist in all study countries to gather additional information, in particular on potential drivers for change.</p><p><strong>Results: </strong>In all case study countries, community pharmacies offer a range of medicines-related and non-medicines-related services, ranging from core activities such as dispensing and counselling to information on general health topics, point-of-care testing, disposal of returned medicines and needle-exchange programs. Certain services are only permitted in some countries (e.g., vaccinations, generic substitution). Developments (e.g., additional tasks) were observed in the last decades, but some changes were only introduced recently in response to the pandemic (e.g., testing for COVID-19, COVID-19 vaccinations). Several, mostly facilitating, factors, such as high accessibility and acceptance of community pharmacies, the growing relevance of the primary health care concept and an appetite of community pharmacists to take over additional tasks, have contributed to changes in the range of services in community pharmacy in recent years and over the decades.</p><p><strong>Conclusions: </strong>The study confirms changes in community pharmacy, with overall extension of the services offered. The COVID-19 pandemic was reported to have played an important role but was not considered the sole driver for change.</p>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":" ","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research in Social & Administrative Pharmacy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.sapharm.2025.03.001","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Community pharmacy appears to have undergone considerable change over the years.
Objectives: The objective of this research is to study the range of community pharmacy services provided in late stages of the COVID-19 pandemic and during the last decades and to identify potential drivers for change.
Methods: Four European countries (Austria, England, Estonia, and Portugal), which represent a balance in terms of income, organization of the health system and pharmacy services, were selected as case studies. For each country, a factsheet on pharmacy services provided in 2023 and recent developments was populated based on a literature review and validated by country experts in community pharmacies. A semi-structured interview was conducted with a community pharmacist in all study countries to gather additional information, in particular on potential drivers for change.
Results: In all case study countries, community pharmacies offer a range of medicines-related and non-medicines-related services, ranging from core activities such as dispensing and counselling to information on general health topics, point-of-care testing, disposal of returned medicines and needle-exchange programs. Certain services are only permitted in some countries (e.g., vaccinations, generic substitution). Developments (e.g., additional tasks) were observed in the last decades, but some changes were only introduced recently in response to the pandemic (e.g., testing for COVID-19, COVID-19 vaccinations). Several, mostly facilitating, factors, such as high accessibility and acceptance of community pharmacies, the growing relevance of the primary health care concept and an appetite of community pharmacists to take over additional tasks, have contributed to changes in the range of services in community pharmacy in recent years and over the decades.
Conclusions: The study confirms changes in community pharmacy, with overall extension of the services offered. The COVID-19 pandemic was reported to have played an important role but was not considered the sole driver for change.
期刊介绍:
Research in Social and Administrative Pharmacy (RSAP) is a quarterly publication featuring original scientific reports and comprehensive review articles in the social and administrative pharmaceutical sciences. Topics of interest include outcomes evaluation of products, programs, or services; pharmacoepidemiology; medication adherence; direct-to-consumer advertising of prescription medications; disease state management; health systems reform; drug marketing; medication distribution systems such as e-prescribing; web-based pharmaceutical/medical services; drug commerce and re-importation; and health professions workforce issues.